β-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 12, 2006, Pages 5069-5075

  Birkenfeld, Andreas L ^a   Boschmann, Michael ^a   Moro, Cedric ^b   Adams, Frauke ^a   Heusser, Karsten ^a   Tank, Jens ^a   Diedrich, André ^c   Schroeder, Christoph ^a   Franke, Gabi ^a   Berlan, Michel ^b   Luft, Friedrich C ^a   Lafontan, Max ^b   Jordan, Jens ^a  

^a FRANZ VOLHARD CLINIC   (Germany)

^b CHU RANGUEIL   (France)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; LACTIC ACID; PROPRANOLOL DERIVATIVE; PYRUVIC ACID;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SALVAGE; BODY MASS; CALORIMETRY; CARDIOVASCULAR EFFECT; CELL VIABILITY; DOSE RESPONSE; DRUG INHIBITION; DRUG PROTEIN BINDING; ELECTROCARDIOGRAPHY; ENERGY EXPENDITURE; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; LIPID METABOLISM; LIPID OXIDATION; MALE; METABOLIC REGULATION; MICRODIALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN METABOLISM; SKELETAL MUSCLE;

EID: 33845480315     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1084     Document Type: Article

References (39)

1. Potter LR, Abbey-Hosch S, Dickey DM 2006 Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27:47-72
2. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J 2000 Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14:1345-1351
3. Moro C, Galitzky J, Sengenes C, Crampes F, Lafontan M, Berlan M 2004 Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells. J Pharmacol Exp Ther 308:984-992
4. Sengenes C, Stich V, Berlan M, Hejnova J, Lafontan M, Pariskova Z, Galitzky J 2002 Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women. Int J Obes Relat Metab Disord 26:24-32
5. Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, Lafontan M, Berlan M 2001 The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 42:536-544
6. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Franke G, Berlan M, Luft FC, Lafontan M, Jordan J 2005 Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 90:3622-3628
7. Moro C, Crampes F, Sengenes C, De Glisezinski I, Galitzky J, Thalamas C, Lafontan M, Berlan M 2004 Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J 18:908-910
8. Moro C, Polak J, Hejnova J, Klimcakova E, Crampes F, Stich V, Lafontan M, Berlan M 2006 Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise. Am J Physiol Endocrinol Metab 290:E864-E869
9. Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, Galitzky J 2003 Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 278:48617-48626
10. Floras JS 1990 Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation 81:1860-1873
11. Lappe RW, Todt JA, Wendt RL 1987 Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats. Circ Res 61:134-140
12. Lang CC, Struthers AD 1991 Interactions between atrial natriuretic factor and the autonomic nervous system. Clin Auton Res 1:329-336
13. Jordan J, Tank J, Stoffels M, Franke G, Christensen NJ, Luft FC, Boschmann M 2001 Interaction between β-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab 86:2803-2810
14. Lafontan M, Arner P 1996 Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue. Trends Pharmacol Sci 17:309-313
15. Lonnroth P 1997 Microdialysis in adipose tissue and skeletal muscle. Horm Metab Res 29:344-346
16. Ferrannini E 1988 The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301
17. Bernt E, Gutmann I 1974 Ethanol determination with alcohol dehydrogenase and NAD. In: Bergmeyer HU, ed. Methods of enzymatic analysis. Weinheim, Germany: Verlag Chemie; 1499-1505
18. Hickner RC, Rosdahl H, Borg I, Ungerstedt U, Jorfeldt L, Henriksson J 1992 The ethanol technique of monitoring local blood flow changes in rat skeletal muscle: implications for microdialysis. Acta Physiol Scand 146:87-97
19. Fellander G, Linde B, Bolinder J 1996 Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord 20:220-226
20. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology 1996 Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-1065
21. Haak T, Jungmann E, Hannappel B, Schoffling K 1990 [The effect of atrial natriuretic peptide on glucose tolerance and insulin level]. Med Klin (Munich) 85:61-64
22. Rashed HM, Nair BG, Patel TB 1992 Regulation of hepatic glycolysis and gluconeogenesis by atrial natriuretic peptide. Arch Biochem Biophys 298:640-645
23. Jungmann E, Konzok C, Holl E, Fassbinder W, Schoffling K 1989 Effect of human atrial natriuretic peptide on blood glucose concentrations and hormone stimulation during insulin-induced hypoglycaemia in healthy man. Eur J Clin Pharmacol 36:593-597
24. Cleroux J, Van Nguyen P, Taylor AW, Leenen FH 1989 Effects of β1- vs. β1 + β2-blockade on exercise endurance and muscle metabolism in humans. J Appl Physiol 66:548-554
25. Mora-Rodriguez R, Hodgkinson BJ, Byerley LO, Coyle EF 2001 Effects of β-adrenergic receptor stimulation and blockade on substrate metabolism during submaximal exercise. Am J Physiol Endocrinol Metab 280:E752-E760
26. Kahn BB, Alquier T, Carling D, Hardie DG 2005 AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25
27. Petersen KF, Shulman GI 2006 Etiology of insulin resistance. Am J Med 119:S10-S16
28. Boschmann M, Krupp G, Luft FC, Klaus S, Jordan J 2002 In vivo response to α(1)-adrenoreceptor stimulation in human white adipose tissue. Obes Res 10:555-558
29. Tunstall RJ, Cameron-Smith D 2005 Effect of elevated lipid concentrations on human skeletal muscle gene expression. Metabolism 54:952-959
30. Boschmann M 2001 Heterogeneity of adipose tissue metabolism. In: Klaus S, ed. Adipose tissue. Georgetown, Texas: Landes Bioscience; 131-157
31. Sengenes C, Zakaroff-Girard A, Moulin A, Berlan M, Bouloumie A, Lafontan M, Galitzky J 2002 Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am J Physiol Regul Integr Comp Physiol 283:R257-R265
32. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS 2004 Impact of obesity on plasma natriuretic peptide levels. Circulation 109: 594-600
33. Engeli S, Sharma AM 2001 The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 79:21-29
34. Jaubert J, Jaubert F, Martin N, Washburn LL, Lee BK, Eicher EM, Guenet JL 1999 Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc Natl Acad Sci USA 96: 10278-10283
35. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ 1997 Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349:1050-1053
36. Witteles RM, Tang WH, Jamali AH, Chu JW, Reaven GM, Fowler MB 2004 Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link. J Am Coll Cardiol 44:78-81
37. Lommi J, Kupari M, Yki-Jarvinen H 1998 Free fatty acid kinetics and oxidation in congestive heart failure. Am J Cardiol 81:45-50
38. Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, Marz W 2006 Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 91:2542-2547
39. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K 2005 Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 293:1900-1905